Yahoo Finance Gold Price Prediction – Prices Edge Higher as Momentum Turns Positive
Gold prices edged higher on Wednesday, attempting to slide above resistance and poised to test higher levels. The dollar moved lower, which helped buoy the yellow metal, but there were little movements in US yields which continued to generate headwinds for gold prices. Gold volatility has moved lower dropping down to 20% after hitting a fresh 11-year high at 56% in March. This level is still approximately 13% higher than the 50-week moving average of gold implied volatility which is at 17%.
Traders await Thursday jobless claims data out of the US which if weaker than expected, should help buoy gold prices. The Fed released the April meeting minutes and said that official additional guidance may come later. The Fed also discussed capping rates at specific levels, which would put a floor under riskier assets. Hedge funds remain long futures and options waiting for gold prices to break out further.
Trade gold with FXTM
Technical Analysis
Gold prices edged higher and closed at a fresh 7.5-year high. Short term resistance is seen near the May highs at $1,765. Additional resistance is seen near the October 2012 highs at $1,795. Medium-term momentum has turned positive as the MACD (moving average convergence divergence) index generated a crossover buy signal. This occurs as the MACD line (the 12-day moving average minus the 26-day moving average) crosses above the MACD signal line (the 9-day moving average of the MACD line). The MACD histogram also generated a crossover buy signal. The histogram crossed through the zero-index level and has an upward sloping trajectory which points to higher prices.
This article was originally posted on FX Empire
More From FXEMPIRE:
Mid-Week Themes – Hope Fuels Demand for Crude and Riskier Assets!
Daily Gold News: Wednesday, May 20 – Precious Metals Higher but Gold Unchanged
GBP/USD Price Forecast – The British Pound Has Run Into Resistance, Again
Even FED Chair Powell Gets Ignored. What Will it Take for the Market to Take Its Medicine?
